TN2009000518A1 - Particulates of a crth2 antagonist - Google Patents

Particulates of a crth2 antagonist

Info

Publication number: TN2009000518A1
Authority: TN; Tunisia
Prior art keywords: particulates; crth2 antagonist; crth2; benzamido; pyrimidin
Prior art date: 2007-06-21

Application number

TNP2009000518A

Other languages

English (en)

Inventor

Tai Wei Ly

Hui-Yin Li

Original Assignee

Actimis Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-21

Filing date

2009-12-10

Publication date

2011-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39708813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000518(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-12-10 Application filed by Actimis Pharmaceuticals Inc filed Critical Actimis Pharmaceuticals Inc

2011-03-31 Publication of TN2009000518A1 publication Critical patent/TN2009000518A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Hematology (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

TNP2009000518A 2007-06-21 2009-12-10 Particulates of a crth2 antagonist TN2009000518A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US93697207P	2007-06-21	2007-06-21
PCT/US2008/007589 WO2008156780A1 (fr)	2007-06-21	2008-06-18	Particules d'antagoniste de crth2

Publications (1)

Publication Number	Publication Date
TN2009000518A1 true TN2009000518A1 (en)	2011-03-31

Family

ID=39708813

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000518A TN2009000518A1 (en)	2007-06-21	2009-12-10	Particulates of a crth2 antagonist

Country Status (20)

Country	Link
US (1)	US8507005B2 (fr)
EP (1)	EP2170838A1 (fr)
JP (1)	JP2010530425A (fr)
KR (1)	KR20100023046A (fr)
CN (3)	CN103172573A (fr)
AR (1)	AR067119A1 (fr)
AU (1)	AU2008266853A1 (fr)
BR (1)	BRPI0813436A2 (fr)
CA (1)	CA2690172A1 (fr)
CL (1)	CL2008001818A1 (fr)
CO (1)	CO6290713A2 (fr)
EC (1)	ECSP109890A (fr)
IL (1)	IL202679A0 (fr)
MA (1)	MA31534B1 (fr)
NZ (1)	NZ581811A (fr)
RU (1)	RU2468012C2 (fr)
TN (1)	TN2009000518A1 (fr)
TW (1)	TW200911762A (fr)
UA (1)	UA99138C2 (fr)
WO (1)	WO2008156780A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1471057T3 (da)	2003-04-25	2006-05-15	Actimis Pharmaceuticals Inc	Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2
MX2009013813A (es) *	2007-06-21	2010-02-03	Actimis Pharmaceuticals Inc	Sales de amina de un antagonista de crth2.
US8168678B2 (en)	2008-02-01	2012-05-01	Panmira Pharmaceuticals, Inc.	N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
JP2011513242A (ja)	2008-02-25	2011-04-28	アミラファーマシューティカルズ，インク．	プロスタグランジンｄ２受容体アンタゴニスト
EP2300425A4 (fr)	2008-06-24	2012-03-21	Panmira Pharmaceuticals Llc	Antagonistes de cycloalcaneýb¨indole de récepteurs de prostaglandine d2
GB2463788B (en)	2008-09-29	2010-12-15	Amira Pharmaceuticals Inc	Heteroaryl antagonists of prostaglandin D2 receptors
US8378107B2 (en)	2008-10-01	2013-02-19	Panmira Pharmaceuticals, Llc	Heteroaryl antagonists of prostaglandin D2 receptors
US8524748B2 (en)	2008-10-08	2013-09-03	Panmira Pharmaceuticals, Llc	Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
GB2465062B (en)	2008-11-06	2011-04-13	Amira Pharmaceuticals Inc	Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
US20120142715A1 (en)	2009-07-06	2012-06-07	Boehringer Ingelheim International Gmbh	Polymorph of [4,6-bis(dimethylamino)-2-(4-benzyl)pyrimidin-5-yl]
WO2011014587A2 (fr)	2009-07-31	2011-02-03	Amira Pharmaceuticals, Inc.	Compositions pharmaceutiques ophtalmiques d'antagonsites du récepteur dp2
JP2013501052A (ja)	2009-08-05	2013-01-10	パンミラファーマシューティカルズ，エルエルシー．	Ｄｐ２アンタゴニストおよびその用途
CA2781610A1 (fr)	2009-11-24	2011-06-03	Boehringer Ingelheim International Gmbh	Procede de preparation d'un polymorphe de sel de choline de derive d'acide pyrimidin-5-yl acetique
JP2013512239A (ja)	2009-11-24	2013-04-11	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ピリミジン−５−イル酢酸誘導体の新規な塩の形態
EP2457900A1 (fr)	2010-11-25	2012-05-30	Almirall, S.A.	Nouveaux dérivés de pyrazole présentant un comportement antagoniste CRTH2
CA3064530A1 (fr) *	2017-06-12	2018-12-20	Novartis Ag	Materiaux pharmaceutiques nanostructures amorphes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7078690B2 (en) *	2002-02-04	2006-07-18	Applied Materials, Israel, Ltd.	Monitoring of contact hole production
DK1471057T3 (da) *	2003-04-25	2006-05-15	Actimis Pharmaceuticals Inc	Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2
SI1718649T1 (sl) *	2004-01-31	2009-10-31	Actimis Pharmaceuticals Inc	Derivati imidazo 1,2-c pirimidinilocetne kisline

2008
- 2008-06-18 RU RU2010101804/04A patent/RU2468012C2/ru not_active IP Right Cessation
- 2008-06-18 UA UAA201000542A patent/UA99138C2/ru unknown
- 2008-06-18 CN CN2013100434631A patent/CN103172573A/zh active Pending
- 2008-06-18 CA CA2690172A patent/CA2690172A1/fr not_active Abandoned
- 2008-06-18 CN CN2008801032394A patent/CN101778830B/zh not_active Expired - Fee Related
- 2008-06-18 US US12/665,706 patent/US8507005B2/en not_active Expired - Fee Related
- 2008-06-18 EP EP08768582A patent/EP2170838A1/fr not_active Withdrawn
- 2008-06-18 JP JP2010513234A patent/JP2010530425A/ja active Pending
- 2008-06-18 KR KR1020107001462A patent/KR20100023046A/ko not_active Ceased
- 2008-06-18 WO PCT/US2008/007589 patent/WO2008156780A1/fr not_active Ceased
- 2008-06-18 AU AU2008266853A patent/AU2008266853A1/en not_active Abandoned
- 2008-06-18 BR BRPI0813436-7A2A patent/BRPI0813436A2/pt not_active IP Right Cessation
- 2008-06-18 CN CN2013100434078A patent/CN103172572A/zh active Pending
- 2008-06-18 NZ NZ581811A patent/NZ581811A/xx not_active IP Right Cessation
- 2008-06-19 CL CL2008001818A patent/CL2008001818A1/es unknown
- 2008-06-20 TW TW097123253A patent/TW200911762A/zh unknown
- 2008-06-20 AR ARP080102676A patent/AR067119A1/es not_active Application Discontinuation
2009
- 2009-12-10 TN TNP2009000518A patent/TN2009000518A1/fr unknown
- 2009-12-10 IL IL202679A patent/IL202679A0/en unknown
2010
- 2010-01-19 MA MA32538A patent/MA31534B1/fr unknown
- 2010-01-20 CO CO10005024A patent/CO6290713A2/es not_active Application Discontinuation
- 2010-01-21 EC EC2010009890A patent/ECSP109890A/es unknown

Also Published As

Publication number	Publication date
ECSP109890A (es)	2010-03-31
AU2008266853A1 (en)	2008-12-24
HK1144939A1 (en)	2011-03-18
KR20100023046A (ko)	2010-03-03
US20110052701A1 (en)	2011-03-03
AR067119A1 (es)	2009-09-30
CN103172573A (zh)	2013-06-26
BRPI0813436A2 (pt)	2014-12-23
CO6290713A2 (es)	2011-06-20
RU2468012C2 (ru)	2012-11-27
US8507005B2 (en)	2013-08-13
CL2008001818A1 (es)	2009-03-06
WO2008156780A1 (fr)	2008-12-24
RU2010101804A (ru)	2011-07-27
JP2010530425A (ja)	2010-09-09
CN101778830A (zh)	2010-07-14
IL202679A0 (en)	2010-06-30
CN101778830B (zh)	2013-03-20
CA2690172A1 (fr)	2008-12-24
UA99138C2 (ru)	2012-07-25
TW200911762A (en)	2009-03-16
EP2170838A1 (fr)	2010-04-07
CN103172572A (zh)	2013-06-26
MA31534B1 (fr)	2010-07-01
NZ581811A (en)	2012-11-30

Publication	Publication Date	Title
TN2009000518A1 (en)	2011-03-31	Particulates of a crth2 antagonist
MY149005A (en)	2013-06-28	Amine salts of a crth2 antagonist
WO2008067399A3 (fr)	2008-09-25	Formulation à libération contrôlée d'antagonistes de pipérazine-pipéridine et agonistes du récepteur 5-ht1a ayant une dissolution intestinale amplifiée
EA200901442A1 (ru)	2010-06-30	Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах
WO2009131974A8 (fr)	2010-03-18	Composes de 2-imino-3-methyl-pyrrolo pyrimidinone substitues par thiophenyle utilises en tant qu’inhibiteurs bace-1, compositions et utilisation associees
UA97795C2 (uk)	2012-03-26	Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
MY159522A (en)	2017-01-13	Administration of dipeptidyl peptidase inhibitors
MX2009008253A (es)	2009-10-12	Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
MX2009010037A (es)	2009-11-05	Aminopirimidinas utiles como inhibidores de cinasas.
MX377802B (es)	2025-03-11	Metodos y composiciones para trastornos del sueño y otros trastornos.
WO2008112651A3 (fr)	2008-11-27	Aminopyrimidines utiles en tant qu'inhibiteurs des protéines kinases
EA200801769A1 (ru)	2009-02-27	Тригидрохлориды производного дигидроптеридинона и способы их получения
MX2009009592A (es)	2009-11-10	Aminopiridinas utiles como inhibidores de proteinas cinasas.
WO2007103970A3 (fr)	2007-11-08	Compositions et procédés de traitement de troubles respiratoires
MX2009011811A (es)	2010-01-14	Aminopirimidinas utiles como inhibidores de cinasa.
WO2007106181A3 (fr)	2007-12-06	Antagonistes des récepteurs du glucagon, leur préparation et leurs utilisations thérapeutiques
TN2012000038A1 (en)	2013-09-19	New compositions of 1-[-2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
ATE459619T1 (de)	2010-03-15	Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
IL189603A0 (en)	2008-08-07	Methods and formulations for modulating lyn kinase activity and treating related disorders
WO2010123959A3 (fr)	2011-02-17	Antagonistes ccr3 d'arylsulfonamides 2,5-disubstitués
EA200970875A1 (ru)	2010-04-30	Производные индолизинуксусной кислоты в качестве антагонистов crth2
MX2011009506A (es)	2011-09-28	Antagonista del receptor mineralcorticoide y metodos de uso.
ATE473961T1 (de)	2010-07-15	Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
WO2008014247A3 (fr)	2008-03-20	Éthers hétérocycliques substitués et leur utilisation dans des troubles du système nerveux central
WO2011066147A3 (fr)	2011-09-09	Nouvelles formes salines d'un dérivé de l'acide pyrimidin-5-yl acétique